Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies (Q80977096)
Jump to navigation
Jump to search
scientific article published on 01 August 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies |
scientific article published on 01 August 2005 |
Statements
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies (English)
Maryalice Stetler-Stevenson
Wyndham H Wilson
Robert J Kreitman
David R Squires
Pierre Noel
David J P FitzGerald